Requirement for Serine-384 in Caspase-2 processing and activity.
Journal
Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092
Informations de publication
Date de publication:
03 10 2020
03 10 2020
Historique:
received:
03
06
2020
accepted:
16
09
2020
revised:
14
09
2020
entrez:
4
10
2020
pubmed:
5
10
2020
medline:
14
5
2021
Statut:
epublish
Résumé
Caspase-2 is a unique and conservative cysteine protease which plays an important role in several cellular processes including apoptotic cell death. Although the molecular mechanisms of its activation remain largely unclear, a major role belongs to the architecture of the caspase-2 active center. We demonstrate that the substitution of the putative phosphorylation site of caspase-2, Serine-384 to Alanine, blocks caspase-2 processing and decreases its enzymatic activity. Strikingly, in silico analysis using molecular dynamics simulations has shown that Serine-384 is crucially involved in interactions within the caspase-2 active center. It stabilizes Arginine-378, which forms a crucial hydrogen bond with the aspartate residue of a substrate. Hence, Serine-384 is essential for supporting a proper architecture of the active center of caspase-2. Moreover, molecular modeling strongly proved steric inaccessibility of Ser-384 to be phosphorylated. Importantly, a multiple alignment has demonstrated that both Serine-384 and Arg-378 residues are highly conservative across all members of caspase family, which allows us to suggest that this diade is indispensable for caspase processing and activity. Spontaneous mutations in this diade might influence oncosuppressive function of caspases, in particular of caspase-2. Likewise, the mutation of Ser-384 is associated with the development of lung squamous cell carcinoma and adenocarcinoma. Taken together, we have uncovered a central feature of the caspase-2 activation mechanism which is crucial for the regulation of its signaling network.
Identifiants
pubmed: 33011746
doi: 10.1038/s41419-020-03023-6
pii: 10.1038/s41419-020-03023-6
pmc: PMC7532978
doi:
Substances chimiques
Serine
452VLY9402
CASP2 protein, human
EC 3.4.22.-
Caspase 2
EC 3.4.22.-
Caspase 9
EC 3.4.22.-
Cysteine Endopeptidases
EC 3.4.22.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
825Références
Lavrik, I. N., Golks, A. & Krammer, P. H. Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 115, 2665–2672 (2005).
doi: 10.1172/JCI26252
Olsson, M. & Zhivotovsky, B. Caspases and cancer. Cell Death Differ. 18, 1441–1449 (2011).
doi: 10.1038/cdd.2011.30
Green, D. R. & Llambi, F. Cell death signaling. Cold Spring Harb. Perspect. Biol. 7, a006080 (2015).
doi: 10.1101/cshperspect.a006080
Degterev, A., Boyce, M. & Yuan, J. A decade of caspases. Oncogene 22, 8543–8567 (2003).
doi: 10.1038/sj.onc.1207107
Zamaraev, A. V., Kopeina, G. S., Zhivotovsky, B. & Lavrik, I. N. Cell death controlling complexes and their potential therapeutic role. Cell. Mol. Life Sci. 72, 505–517 (2014).
doi: 10.1007/s00018-014-1757-2
Stennicke, H. R. & Salvesen, G. S. Caspases—controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 1477, 299–306 (2000).
doi: 10.1016/S0167-4838(99)00281-2
Pop, C. & Salvesen, G. S. Human caspases: activation, specificity, and regulation. J. Biol. Chem. 284, 21777–21781 (2009).
doi: 10.1074/jbc.R800084200
Dorstyn, L. et al. Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability. Cell Death Differ. 19, 1411–1411 (2012).
doi: 10.1038/cdd.2012.76
Zamaraev, A. V., Kopeina, G. S., Buchbinder, J. H., Zhivotovsky, B. & Lavrik, I. N. Caspase-2 is a negative regulator of necroptosis. Int. J. Biochem. Cell Biol. 102, 101–108 (2018).
doi: 10.1016/j.biocel.2018.07.006
Prokhorova, E. A., Egorshina, A. Y., Zhivotovsky, B. & Kopeina, G. S. The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death. Oncogene 39, 1–16 (2020).
doi: 10.1038/s41388-019-0980-6
Zamaraev, A. V., Kopeina, G. S., Prokhorova, E. A., Zhivotovsky, B. & Lavrik, I. N. Post-translational modification of Caspases: the other side of apoptosis regulation. Trends Cell Biol. 27, 322–339 (2017).
doi: 10.1016/j.tcb.2017.01.003
Shin, S. et al. Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J. 24, 3532–3542 (2005).
doi: 10.1038/sj.emboj.7600827
Nutt, L. K. et al. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of Caspase-2. Cell 123, 89–103 (2005).
doi: 10.1016/j.cell.2005.07.032
Andersen, J. L. et al. Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2. EMBO J. 28, 3216–3227 (2009).
doi: 10.1038/emboj.2009.253
Bergeron, L. et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12, 1304–1314 (1998).
doi: 10.1101/gad.12.9.1304
Kitevska, T. et al. Analysis of the minimal specificity of caspase-2 and identification of Ac-VDTTD-AFC as a caspase-2-selective peptide substrate. Biosci. Rep. 34, e00100 (2014).
doi: 10.1042/BSR20140025
Schweizer, A., Briand, C. & Grütter, M. G. Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway. J. Biol. Chem. 278, 42441–42447 (2003).
doi: 10.1074/jbc.M304895200
Tang, Y., Wells, J. A. & Arkin, M. R. Structural and enzymatic insights into Caspase-2 protein substrate recognition and catalysis. J. Biol. Chem. 286, 34147–34154 (2011).
doi: 10.1074/jbc.M111.247627
Stennicke, H. & Salvesen, G. Catalytic properties of the caspases. Cell Death Differ. 6, 1054–1059 (1999).
doi: 10.1038/sj.cdd.4400599
Cursi, S. et al. Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J. 25, 1895–1905 (2006).
doi: 10.1038/sj.emboj.7601085
Thomas, M. E., Grinshpon, R., Swartz, P. & Clark, A. C. Modifications to a common phosphorylation network provide individualized control in caspases. J. Biol. Chem. 293, 5447–5461 (2018).
doi: 10.1074/jbc.RA117.000728
McDonnell, M. A. et al. Phosphorylation of murine Caspase-9 by the protein kinase casein kinase 2 regulates its cleavage by Caspase-8. J. Biol. Chem. 283, 20149–20158 (2008).
doi: 10.1074/jbc.M802846200
Fu, Y. et al. Dasatinib reduces 5-Fu-triggered apoptosis in colon carcinoma by directly modulating Src-dependent caspase-9 phosphorylation. Cell Death Discov. 4, 61 (2018).
doi: 10.1038/s41420-018-0062-5
Peng, C. et al. Phosphorylation of Caspase-8 (Thr-263) by Ribosomal S6 Kinase 2 (RSK2) mediates Caspase-8 ubiquitination and stability. J. Biol. Chem. 286, 6946–6954 (2011).
doi: 10.1074/jbc.M110.172338
Martin, M. C. et al. Protein kinase a regulates Caspase-9 activation by Apaf-1 downstream of Cytochrome c. J. Biol. Chem. 280, 15449–15455 (2005).
doi: 10.1074/jbc.M414325200
Lim, Y. et al. Phosphorylation by Aurora B kinase regulates caspase-2 activity and function. Preprint at https://www.biorxiv.org/content/ https://doi.org/10.1101/2020.03.05.978056v1 (2020).
Salomon-Ferrer, R., Case, D. A. & Walker, R. C. An overview of the Amber biomolecular simulation package. Wiley Interdiscip. Rev. Comput. Mol. Sci. 3, 198–210 (2013).
doi: 10.1002/wcms.1121
Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696–3713 (2015).
doi: 10.1021/acs.jctc.5b00255
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
doi: 10.1016/0263-7855(96)00018-5